Ana Tereza Ribeiro de Vasconcelos

Dr. Ana Tereza Ribeiro de Vasconcelos

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 September 2020 in Science
Verified
Journal Article
Open access
DCDarlan S. Candido
Darlan S. Candido
ICIngra M. Claro
Ingra M. Claro
JJJaqueline de Jesus
Jaqueline de Jesus
William SouzaWilliam Souza
William Souza
FMFilipe Moreira
Filipe Moreira
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
The spread of SARS-CoV-2 in Brazil: Brazil has been hard-hit by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic. Candido et al. combined genomic and epidemiological analyses to investigate the impact of nonpharmaceutical interventions (NPIs) in the country. By setting up a network of genomic laboratories using harmonized protocols, the researchers found a 29% positive rate for SARS-CoV-2 among collected samples. More than 100 international introductions of SARS-CoV-2 into Brazil were identified, including three clades introduced from Europe that were already well established before the implementation of NPIs and travel bans. The virus spread from urban centers to the rest of the country, along with a 25% increase in the average distance traveled by air passengers before travel bans, despite an overall drop in short-haul travel. Unfortunately, the evidence confirms that current interventions remain insufficient to keep virus transmission under control in Brazil. Science , this issue p. 1255

11 November 2020 in Nature
Verified
Journal Article
Open access
PDF file
SFShaohong Feng
Shaohong Feng
JSJosefin Stiller
Josefin Stiller
YDYuan Deng
Yuan Deng
JAJoel Armstrong
Joel Armstrong
QFQi Fang
Qi Fang
GZGuojie Zhang
Guojie Zhang
Whole-genome sequencing projects are increasingly populating the tree of life and characterizing biodiversity1,2,3,4. Sparse taxon sampling has previously been proposed to confound phylogenetic inference5, and captures only a fraction of the genomic diversity. Here we report a substantial step towards the dense representation of avian phylogenetic and molecular diversity, by analysing 363 genomes from 92.4% of bird families—including 267 newly sequenced genomes produced for phase II of the Bird 10,000 Genomes (B10K) Project. We use this comparative genome dataset in combination with a pipeline that leverages a reference-free whole-genome alignment to identify orthologous regions in greater numbers than has previously been possible and to recognize genomic novelties in particular bird lineages. The densely sampled alignment provides a single-base-pair map of selection, has more than doubled the fraction of bases that are confidently predicted to be under conservation and reveals extensive patterns of weak selection in predominantly non-coding DNA. Our results demonstrate that increasing the diversity of genomes used in comparative studies can reveal more shared and lineage-specific variation, and improve the investigation of genomic characteristics. We anticipate that this genomic resource will offer new perspectives on evolutionary processes in cross-species comparative analyses and assist in efforts to conserve species.

5 October 2008 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
LALuiz G P de Almeida
Luiz G P de Almeida
NSNoboru J. Sakabe
Noboru J. Sakabe
ADAlice R. Deoliveira
Alice R. Deoliveira
MSMaria Cristina C. Silva
Maria Cristina C. Silva
AMAlex S. Mundstein
Alex S. Mundstein
AVAna Tereza Ribeiro de Vasconcelos
Ana Tereza Ribeiro de Vasconcelos
The potency of the immune response has still to be harnessed effectively to combat human cancers. However, the discovery of T-cell targets in melanomas and other tumors has raised the possibility that cancer vaccines can be used to induce a therapeutically effective immune response against cancer. The targets, cancer-testis (CT) antigens, are immunogenic proteins preferentially expressed in normal gametogenic tissues and different histological types of tumors. Therapeutic cancer vaccines directed against CT antigens are currently in late-stage clinical trials testing whether they can delay or prevent recurrence of lung cancer and melanoma following surgical removal of primary tumors. CT antigens constitute a large, but ill-defined, family of proteins that exhibit a remarkably restricted expression. Currently, there is a considerable amount of information about these proteins, but the data are scattered through the literature and in several bioinformatic databases. The database presented here, CTdatabase (http://www.cta.lncc.br), unifies this knowledge to facilitate both the mining of the existing deluge of data, and the identification of proteins alleged to be CT antigens, but that do not have their characteristic restricted expression pattern. CTdatabase is more than a repository of CT antigen data, since all the available information was carefully curated and annotated with most data being specifically processed for CT antigens and stored locally. Starting from a compilation of known CT antigens, CTdatabase provides basic information including gene names and aliases, RefSeq accession numbers, genomic location, known splicing variants, gene duplications and additional family members. Gene expression at the mRNA level in normal and tumor tissues has been collated from publicly available data obtained by several different technologies. Manually curated data related to mRNA and protein expression, and antigen-specific immune responses in cancer patients are also available, together with links to PubMed for relevant CT antigen articles.

16 November 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ABAnderson F. Brito
Anderson F. Brito
ESElizaveta Semenova
Elizaveta Semenova
GDGytis Dudas
Gytis Dudas
GHGabriel W. Hassler
Gabriel W. Hassler
CKChaney C. Kalinich
Chaney C. Kalinich
NFNuno Rodrigues Faria
Nuno Rodrigues Faria
Genomic sequencing is essential to track the evolution and spread of SARS-CoV-2, optimize molecular tests, treatments, vaccines, and guide public health responses. To investigate the global SARS-CoV-2 genomic surveillance, we used sequences shared via GISAID to estimate the impact of sequencing intensity and turnaround times on variant detection in 189 countries. In the first two years of the pandemic, 78% of high-income countries sequenced >0.5% of their COVID-19 cases, while 42% of low- and middle-income countries reached that mark. Around 25% of the genomes from high income countries were submitted within 21 days, a pattern observed in 5% of the genomes from low- and middle-income countries. We found that sequencing around 0.5% of the cases, with a turnaround time <21 days, could provide a benchmark for SARS-CoV-2 genomic surveillance. Socioeconomic inequalities undermine the global pandemic preparedness, and efforts must be made to support low- and middle-income countries improve their local sequencing capacity.

26 April 2021 in Journal of Virology
Verified
Journal Article
Open access
CVCarolina M. Voloch
Carolina M. Voloch
RFRonaldo da Silva Francisco
Ronaldo da Silva Francisco
LALuiz G. P. de Almeida
Luiz G. P. de Almeida
CCCynthia C. Cardoso
Cynthia C. Cardoso
OBOtavio J. Brustolini
Otavio J. Brustolini
LWLncc Workgroup
Lncc Workgroup
Almost simultaneously, several studies reported the emergence of novel SARS-CoV-2 lineages characterized by their phylogenetic and genetic distinction (1), (2), (3), (4).….

15 August 2005 in Journal of Bacteriology
Verified
Journal Article
Open access
PDF file
AVAna Tereza Ribeiro de Vasconcelos
Ana Tereza Ribeiro de Vasconcelos
HFHenrique B. Ferreira
Henrique B. Ferreira
Cristiano BizarroCristiano Bizarro
Cristiano Bizarro
SBSandro L. Bonatto
Sandro L. Bonatto
MCMarcos O. Carvalho
Marcos O. Carvalho
AZArnaldo Zaha
Arnaldo Zaha
This work reports the results of analyses of three complete mycoplasma genomes, a pathogenic (7448) and a nonpathogenic (J) strain of the swine pathogenMycoplasma hyopneumoniaeand a strain of the avian pathogenMycoplasma synoviae; the genome sizes of the three strains were 920,079 bp, 897,405 bp, and 799,476 bp, respectively. These genomes were compared with other sequenced mycoplasma genomes reported in the literature to examine several aspects of mycoplasma evolution. Strain-specific regions, including integrative and conjugal elements, and genome rearrangements and alterations in adhesin sequences were observed in theM. hyopneumoniaestrains, and all of these were potentially related to pathogenicity. Genomic comparisons revealed that reduction in genome size implied loss of redundant metabolic pathways, with maintenance of alternative routes in different species. Horizontal gene transfer was consistently observed betweenM. synoviaeandMycoplasma gallisepticum. Our analyses indicated a likely transfer event of hemagglutinin-coding DNA sequences fromM. gallisepticumtoM. synoviae.